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INTRODUCTION: 
Decalepsis Hamiltonii (Wight& Arn), popularly known as 
swallow root in English, belongs to the family 
Asclepiadaceae. It is a climber with stout, smooth 
branches shrub and a native of the forests of Deccan 
peninsula and Western Ghats of India. The leaves are 
curvaceous, orbicular or elliptical, with rounded tip.  Its 
tubers are consumed as pickles and the juice for its alleged 
health promoting properties The Root has a sweet 
sarsaparilla-like taste; contains 9.2% fleshy matter and 8% 
woody core)1. It contains quercetin, kaempferol, coumarin 
and rutin and considered as “Sariva Bheda” in Ayurveda 
where these find use as an alternative to the roots of 
Hemidesmus indicus in the preparation of several herbal 
drugs like Amrutamalaka taila (hair tonic), Drakshadi 
churna (general vitalizer), Shatavari rasayana 
(adapatogenic) and Yeshtimadhu taila (mild analgesic, anti 
rheumatism). The root can be stored for longer period and 
remains unaffected by microorganisms and insects, 
apparently due to the presence of a volatile principle with 
bacteriostatic and toxic properties which can be isolated by 
steam distillation. It has been extensively used as 
preservative and also as a source of bio insecticide in 
stored food grains due to the presence of strong aroma and 
4-0-methyl resorcylaldehyde (0.9-12%.).2 
Although the roots of D.  hamiltonii have been used for 
their alleged health benefits, scientific investigation in this 
regard need to be done.  Though many researchers 
establish the anti oxidant, anti bacterial and anti 
ulcerogenic role of the root extract of D. hamiltonii, very 
few have explored the anti inflammatory potential. The 
anti-inflammatory drugs (NSAIDs) presently available are 
not free of side effects like gastric ulceration, kidney 
damage etc so an alternative drug obtained from natural 
sources devoid of side effects would be useful in treatment 
of acute and chronic inflammatory diseases. The aim of the 
present study was therefore to evaluate the acute & chronic 
anti-inflammatory activities of the extract of root of 
Decalepsis Hamiltonii in rodents. 
MATERIALS & METHOD:  
Animals 
Albino rats of either sex weighing between 150-200 grams 
were used for this experiment. The rats were kept in 
polysulfone rat cages and maintained at a 12 h light / dark 
cycle. The temperature was maintained at 22 - 26
o
C while 
the relative humidity was 50-60%. The experiment was 
conducted in the Department of Pharmacology, Medical 
College Kolkata in collaboration with West Bengal 
University of Animal and Fishery Sciences, Mohanpur 
Campus. Rats were fed on standard pellet diet and 
provided filtered autoclaved ad libitum drinking water. 
The experiments were performed following approval by 
the Institutional Animal Ethics Committee of WBUAFS.  
Plant Extract 
Powdered root of Decalepsis Hamiltonii (5 Kg) was 
obtained from the Chemical Research and Extraction. 
Supply Unit of CCRAS and extracted with petrol ether 
(60
o
–80
o
 C) in sox let apparatus for 15 hours and solvent 
was removed by distillation. The residual gummy material 
obtained was then suspended in 5% gum acacia and used 
for oral administration to the experimental animals at a 
dose of 250 mg/ kg body wt after standardizing   according 
to their LD 50 & ED 50 determined before selecting the 
dose. 
ABSTRACT: 
Powdered root of Decalepsis hamiltonii was used to evaluate the acute & chronic anti-inflammatory activities in rodents. Albino 
rats of either sex were divided into 4 sets (n=24). Set A, B, C was used for evaluating the anti inflammatory activity after inducing 
acute inflammation with Carrageenan, bradykinin and 5HT respectively while Set D was used for evaluating the anti inflammatory 
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sets, GR I served as control (receiving gum acacia only), GR II received root extract of D. hamiltonii at the dose of 250mg /kg, GR 
III received Phenylbutazone 50 mg / Kg, and GR IV received Dexamethasone 0.5 mg / Kg. There was inflammatory inhibition of 
35.55% in Carrageenan induced, 42.62% in 5HT induced and 36.62% in bradykinin induced acute inflammatory models. In the 
chronic Inflammatory model, a progressive inhibition of 36.84% (3rd day), 36.45% (5th day), 51.45% (7th day) and 66.39% (13th 
day) was observed with study compound. The efficacy was comparable to the standard drugs. To summarize, we can say that 
Decalepsis hamiltonii is an anti-inflammatory and anti arthritic agent that may block histamine and serotonin path way. It may be an 
effective alternative to NSAIDs and corticosteroids in inflammatory disorders.  
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Drugs and Chemicals: 
Carrageenan (sigma), 5HT (Roche Pharmaceuticals), 
Bradykinin (BRA 640, San Doz),   Formaldehyde, 
Phenylbutazone (SG Pharmaceuticals), Dexamethasone 
(MSD), Gum acacia.  
 Procedure:     
As the indigenous drug was insoluble in water it was 
suspended in 5% gum acacia solution. The rats were 
divided in five groups (n=6) and the drugs were given 
orally with the help of rat feeding canula fitted to 2 ml 
glass syringe keeping the volume of medicament constant 
(1ml)  one  hour prior to Carrageenan  injection (for 
inducing inflammation).  
  GR I served as control (receiving gum acacia only) 
  GR II received root extract of D. hamiltonii, 250mg/kg  
  GR III received root extract of D. hamiltonii, 500mg/kg  
  GR IV received Phenylbutazone 50 mg / Kg  
  GRV received Dexamethasone 0.5 mg / Kg  
The average volume of hind paw of all the rats was 
measured with the help of a plethismograph by the method 
of Buttle et al 3 after some modification and noted before 
inducing acute inflammation with Carrageenan.  
Paw edema induced to produce acute inflammation:  
Carrageenan, 5HT and bradykinin induced edema was 
adopted as introduced by Winter, Risley and Nuss4 with 
slight modification by Ghosh & Singh. 5  Carrageenan 1% 
in 0.9% w/v Sodium Chloride was taken and 0.1 ml of 
such solution was injected in sub planter region of hind 
paw of all the rats one hour after the administration of the 
drugs. The paw volume was again measured twice after 1 
hour and at the end of 3 hours and noted.  Increase in 
volume of paw edema was recorded by subtracting the 
initial paw volume from final paw volume measured with 
the help of Plethysmograph after 1 hour and 3 hours of 
Carrageenan injection. 
 Percentage of inhibition of inflammation rate was 
calculated as  
Vc –Vt 
            -------------------- x 100 
Vc 
Where  
Vc- mean increase in volume of paw edema in 
control group. 
Vt- means increase in paw volume of treated 
group of animals. 
Same procedure is followed after inducing acute 
inflammation with sub planter injection of 0.1 ml of 1% 
sol of 5HT and 0 .1 ml 1 micro gram of bradykinin 
respectively.      
Paw edema induced to produce chronic / 
immunologically induced inflammation (arthritis model) 
A new set of rats were taken and grouped in a similar 
manner and the established method was followed to 
produce chronic inflammation. A volume of 0.1 ml of 2% 
formaldehyde (arthritis model) was injected into the sub 
planter region of the left hind paw of each rat. The degree 
of inflammation was assessed by measuring the paw 
volume daily for 13 days according to the method of Buttle 
et al .  As in acute inflammation, Groups I, II, III, IV 
received the drugs once daily orally in similar dosage for 
13 days. The degree of inflammation was tabulated on 
alternate days till the 13th day and compared as shown in 
Table IV.  Percentage of inhibition of inflammation rate 
was calculated in a similar manner. 
Statistical analysis:  
The results were obtained in mean SE and comparison 
between the control and experiment groups was done. 
Statistical analysis was carried out by one-way analysis of 
variance (ANOVA) and P<0.05was considered as 
significant.  
RESULTS:  
The effects of Decalepsis hamiltonii, Phenylbutazone and 
Dexamethasone on Carrageenan, 5HT and bradykinin 
induced edema of rat hind paw is shown in Table no I, II & 
III respectively and Graph I& II.   There was inflammatory 
inhibition of 35.55% in carrageenan induced, 42.62% in 
5HT induced and 36.62% in bradykinin induced acute 
inflammatory models with study compound. In the 
formaldehyde induced chronic Inflammatory model, a 
progressive inhibition of 36.84% (3
rd
 day), 36.45% (5th 
day), 51.45% (7th day) and 66.39% (13th day) was 
observed with study compound. The efficacy was 
comparable to the standard drugs phenylbutazone and 
Dexamethasone. (Table IV)  
 
Table-I: Effects of Decalepsis hamiltonii, Phenylbutazone and Dexamethasone on carrageenan induced edema of rat 
hind paw (n=6) 
 
 
 
 
 
 
 
 
Group Mean increase in paw volume (in ml  SE) % inhibition P Value 
GR I 0.9  0.10 - - 
GR II 0.58 ±0.06 35.55 P<.05 
GR III 0.43±0.11   
GR IV 0.23  0.02 74.44 P<.001 
GR V 0.3  0.03 66.66 P<.01 
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Table-II: Effects of Decalepsis hamiltonii, Phenylbutazone and Dexamethasone on 5HT induced paw edema of rat 
hind paw ( n=6) 
 
Table-III: Effects of Decalepsis hamiltonii, Phenylbutazone and Dexamethasone onBradykinin induced paw edema 
of rat hind paw (n=6) 
 
TABLE – IV: Effects of Decalepsis hamiltonii, Phenylbutazone and Dexamethasone on Formaldehyde induced paw 
edema in rats (n=6) 
 
DISCUSSION: 
Medicinal plants are nature's hidden and to a large extent 
unexplored treasure. They have been used as a source of 
safe and effective medicine since time immemorial, as they 
are less toxic, cheap and suitable for use over a prolonged 
period.  This potential resource has hardly been 
commercially tapped. India is endowed with about 8000 
species of medicinal plants. According to a recent estimate 
of the Planning Commission, Government of India, the 
potential for plant-based crude drugs is about Rs. 400 
billion. Globally, the demand for medicinal plants and 
their derivatives is growing at a rate of 7-15%.Only a few 
medicinal plants have been selected for scientific testing 
and experimentation as inflammatory agents. Moreover, 
the active principles responsible for the alleged health 
promoting activity need to be isolated to elucidate their 
exact mode of action. 
Chopra6 pioneered the usefulness of indigenous drugs 
various diseases including arthritic conditions. Earlier 
works have shown that the D. hamiltonii roots contain 
aldelydes, amyrins, lupeols and volatile flavour 
compounds such as 2-hydroxy-4methoxybenzaldehyde, 
vanillin etc and essential oil like 4-
methylresorcylaldehyde, atlantone, terpinene, geraniol etc. 
A combinational molecule containing pectic 
polysaccharide with bound phenolics identified in the root 
of D. hamiltonii and their break down products have been 
known to have health beneficial properties.7. This highly 
aromatic root has been subjected to over exploitation by 
destructive harvesting that has endangered the survival of 
this plant. A method for rooting of D. hamiltonii for field 
transfer is reported8. 
Flavonoids and occasionally polysaccharides present in 
various plant products have frequently been implicated as 
antioxidant and antiulcer agents9. Various workers have 
proved the antibacterial activity supercritical extract of 
swallow root10. Some claim that it is gastro protective in 
nature and possibly inhibits the H+K+ ATPase enzyme 
responsible for HCl secretion in stomach.11 while some 
state that it has multistep ulcer protective activity,12  and 
antioxidative properties13. The inhibition of carageenan-
induced inflammation in rats is an established model to 
screen compounds for potential anti-inflammatory activity. 
According to Vinegar et al 14 the development of carrageen 
induced edema is biphasic; the first phase occurs within 
one hour of carageenan administration and attributed to the 
release of cytoplasmic enzymes, histamine and serotonin, 
from the mast cells. The second phase (>1.0 h) is mediated 
by an increased release of prostaglandins in inflammatory 
area and continuity between the two phases is maintained 
by kinins. Taken together, it suggests root of D hamiltonii 
possesses potent anti-inflammatory activity (Table I-III) 
possibly due to inhibition and/or release of inflammatory 
mediators, principally the prostaglandins. Anti 
inflammatory effect is also seen in inflammation produced 
Group Mean increase in paw volume (in ml  SE) % inhibition P Value 
GR I 0.61  0.04 - - 
GR II 0.35  0.05 42.62 P <.01 
GR III 0.18  0.03 70.49 P <.001 
GR IV 0.3  0.03 50.81 P<.001 
Group Mean increase in paw volume (in ml  SE) % inhibition P Value 
GR I 0.71  03 - - 
GR II 0.45  0.04 36.62 P <.01 
GR III 0.22  0.4 69.01 P <.001 
GR IV 0.32  0.03 54.92 P<.001 
Group Mean increase in Paw Volume (ml  SE) 
 3
rd
 Day 5
th
 Day 7
th
 Day 9
th
 Day 11
th
 Day 13
th
 Day 
      GR I 0.95  0.02 0.96  0.02 1.03  0.05 1.16  0.12 1.23  0.13 1.13  0.09 
    GR II 0.71  0.03 
25.26% 
P < .001 
0.66  0.04 
31.25% 
P < .001 
0.63  0.04 
38.83% 
P < .001 
0.6  0.03 
48.27% 
P < .01 
0.55  0.03 
55.28% 
P < .01 
0.5  0.05 
55.75% 
P <. 001 
       GR III 0.7  0.03 
26.32% 
P < .001 
0.65  0.02 
32.29% 
P < .001 
0.62  0.04 
39.80% 
P < .001 
0.58  0.03 
59% 
P < .01 
0.5  0.04 
59.34% 
P < .01 
0.4  0.04 
64.60% 
P < .001 
     GRIV 0.60  0.6 
36.84% 
P < .01 
0.61  0.06 
36.45% 
P < .01 
0.50  0.06 
51.45% 
P < .001 
0.46  0.04 
60.34% 
P < .01 
0.43  0.04 
65.50% 
P < .01 
0.38  0.03 
66.39% 
P < .001 
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by 5HT and Bradykinin, that proves it may have some 
action by inhibiting the pain pathway that caused by 5HT 
and Bradykinin.  
Formaldehyde induced arthritis is generally used to study 
the efficacy of a drug against the proliferative phase of 
inflammation i.e. chronic inflammation.  There was 
significant inhibition of formaldehyde induced paw edema 
by Decalepsis hamiltonii with the increase of number of 
days which suggests that it would be beneficial in 
treatment of arthritis and related disorders. Results of the 
present study corroborate with Lakshman et al15 who 
examined the effectiveness of the methanol extract of roots 
of Decalepis hamiltonii at 250 and 500 mg/kg doses orally 
in the carrageenan-induced rat paw edema and cotton 
pellet-induced chronic inflammatory models. The extract 
showed significant dose-dependent anti-inflammatory 
activities in both models. 
Though efficacy of phenylbutazone was the most in acute 
inflammatory model and dexamethasone was most 
efficacious in chronic inflammation, study compound 
exhibited a comparable result in both the models. 
Though NSAIDs are most commonly used in the treatment 
of acute and chronic inflammation, prolonged use has been 
limited as approximately 25% of NSAID users develop G.I 
symptoms16. The advent of this herbal medicine with 
antibacterial, anti oxidative anti-inflammatory and gastro 
protective action together therefore would be unique and 
highly beneficial to patients of acute inflammation and 
particularly chronic inflammatory disorders. It would be 
judicious to identify the specific active principles 
responsible for this anti inflammatory activity which 
would enhance the efficacy of this herbal preparation. 
Further studies in this regard in higher animals are 
recommended for positive outcome.  
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